Growth Hormone Deficiency in Children Clinical Trials

26 clinical trials for Growth Hormone Deficiency in Children across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• GB06 Phase III Trial for Pediatric Growth Hormone Deficiency — RECRUITING · PHASE3
• Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed — RECRUITING
• Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA) — RECRUITING
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) — COMPLETED · PHASE3
• Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency — COMPLETED · PHASE2
• A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day. — COMPLETED · PHASE3
• A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® in children with growth hormone deficiency — OTHER · PHASE3
• Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency — NOT_YET_RECRUITING · PHASE2
• A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency — COMPLETED · PHASE1
• First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects — COMPLETED · PHASE1
• Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD) — COMPLETED
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function — COMPLETED · PHASE1
• Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy — COMPLETED
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. — COMPLETED · PHASE1
• Observational Prospective Study on Patients Treated With Norditropin® — COMPLETED
• Liquid Somatropin Formulation in Children With Growth Hormone Deficiency — COMPLETED · PHASE4
• Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency — COMPLETED · PHASE3
• Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents — COMPLETED · PHASE4
• Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency — COMPLETED · PHASE3
• A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone — COMPLETED · PHASE2
• Effect of Growth Hormone in Children With Growth Hormone Deficiency — COMPLETED · PHASE3
• Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ — COMPLETED
• Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome — COMPLETED
• Safety and Efficacy of Long-term Somatropin Treatment in Children — COMPLETED
• An Observational Study on Treatment Compliance by Children Treated With Growth Hormone — WITHDRAWN
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone — COMPLETED

Refine this search